S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
NASDAQ:TTOO

T2 Biosystems (TTOO) Stock Forecast, Price & News

$0.07
-0.01 (-12.41%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.06
$0.09
50-Day Range
$0.07
$0.46
52-Week Range
$0.06
$15.00
Volume
87.02 million shs
Average Volume
41.99 million shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

T2 Biosystems MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3,441.1% Upside
$2.50 Price Target
Short Interest
Healthy
2.04% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.60mentions of T2 Biosystems in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$115 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars


TTOO stock logo

About T2 Biosystems (NASDAQ:TTOO) Stock

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria panel, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat panel for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris panel to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme panel, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Receive TTOO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter.

TTOO Stock News Headlines

T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Why Is T2 Biosystems (TTOO) Stock Up 17% Today?
Why Is T2 Biosystems (TTOO) Stock Up 29% Today?
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
TTOO T2 Biosystems, Inc.
Diagnostics maker T2 Biosystems lays off 40
T2 Biosystems (TTOO) Receives a Hold from BTIG
Q1 2023 T2 Biosystems Inc Earnings Call
T2 Biosystems earnings preview: what Wall Street is expecting
T2 Biosystems To Explore All Potential Strategic Alternatives
T2 Biosystems's Earnings: A Preview
See More Headlines

TTOO Price History

TTOO Company Calendar

Last Earnings
11/04/2021
Today
6/10/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TTOO
Employees
158
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.50
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+3,441.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-62,000,000.00
Net Margins
-370.13%
Pretax Margin
-370.13%

Debt

Sales & Book Value

Annual Sales
$22.31 million
Book Value
($5.14) per share

Miscellaneous

Free Float
24,074,000
Market Cap
$1.76 million
Optionable
Optionable
Beta
0.35

Key Executives

  • Mr. John J. Sperzel III (Age 60)
    B.Sc., Pres, CEO & Chairman
    Comp: $865.5k
  • Mr. John M. Sprague CPA (Age 65)
    Chief Financial Officer
    Comp: $482.33k
  • Mr. Michael Terrence Gibbs Esq.Mr. Michael Terrence Gibbs Esq. (Age 52)
    Sr. VP & Gen. Counsel
    Comp: $487.33k
  • Ms. Kelley J. Morgan (Age 47)
    Chief People Officer
  • Dr. Aparna Jha Ahuja M.D. (Age 56)
    Chief Medical Officer & Chairman of Scientific Advisory Board
  • Mr. Brett A. Giffin (Age 64)
    Chief Commercial Officer
  • Dr. Roger Smith Ph.D. (Age 58)
    Sr. VP of Science R&D













TTOO Stock - Frequently Asked Questions

Should I buy or sell T2 Biosystems stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for T2 Biosystems in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TTOO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TTOO, but not buy additional shares or sell existing shares.
View TTOO analyst ratings
or view top-rated stocks.

What is T2 Biosystems' stock price forecast for 2023?

4 equities research analysts have issued 12 month price objectives for T2 Biosystems' stock. Their TTOO share price forecasts range from $2.50 to $2.50. On average, they expect the company's stock price to reach $2.50 in the next twelve months. This suggests a possible upside of 3,441.1% from the stock's current price.
View analysts price targets for TTOO
or view top-rated stocks among Wall Street analysts.

How have TTOO shares performed in 2023?

T2 Biosystems' stock was trading at $1.42 at the start of the year. Since then, TTOO stock has decreased by 95.0% and is now trading at $0.0706.
View the best growth stocks for 2023 here
.

When is T2 Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our TTOO earnings forecast
.

How were T2 Biosystems' earnings last quarter?

T2 Biosystems, Inc. (NASDAQ:TTOO) posted its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported ($4.00) earnings per share for the quarter, hitting analysts' consensus estimates of ($4.00). The medical equipment provider earned $7.43 million during the quarter. During the same quarter in the prior year, the firm earned ($4.00) EPS.

When did T2 Biosystems' stock split?

T2 Biosystems's stock reverse split before market open on Thursday, October 13th 2022. The 1-50 reverse split was announced on Thursday, October 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What is John McDonough's approval rating as T2 Biosystems' CEO?

36 employees have rated T2 Biosystems Chief Executive Officer John McDonough on Glassdoor.com. John McDonough has an approval rating of 54% among the company's employees. This puts John McDonough in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of T2 Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other T2 Biosystems investors own include Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV), Tonix Pharmaceuticals (TNXP), OPKO Health (OPK), SCYNEXIS (SCYX), Biocept (BIOC), Heat Biologics (HTBX), NVIDIA (NVDA) and Vaxart (VXRT).

What is T2 Biosystems' stock symbol?

T2 Biosystems trades on the NASDAQ under the ticker symbol "TTOO."

Who are T2 Biosystems' major shareholders?

T2 Biosystems' stock is owned by a variety of retail and institutional investors. Top institutional investors include Sabby Management LLC (3.70%), Hudson Bay Capital Management LP (3.21%), CVI Holdings LLC (2.71%), Anson Funds Management LP (2.59%), Anson Funds Management LP (2.59%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Adrian M Jones, Alec Barclay, Brett A Giffin, Goldman Sachs & Co Llc, John J Sperzel III, John M Sprague, John Mcdonough and Michael Terrence Gibbs.
View institutional ownership trends
.

How do I buy shares of T2 Biosystems?

Shares of TTOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is T2 Biosystems' stock price today?

One share of TTOO stock can currently be purchased for approximately $0.07.

How much money does T2 Biosystems make?

T2 Biosystems (NASDAQ:TTOO) has a market capitalization of $1.76 million and generates $22.31 million in revenue each year.

How many employees does T2 Biosystems have?

The company employs 158 workers across the globe.

How can I contact T2 Biosystems?

T2 Biosystems' mailing address is 101 HARTWELL AVENUE, LEXINGTON MA, 02421. The official website for the company is www.t2biosystems.com. The medical equipment provider can be reached via phone at (781) 761-4646, via email at ir@t2biosystems.com, or via fax at 781-357-3080.

This page (NASDAQ:TTOO) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -